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T-agglutinin is the term usually applied to the substance which is present in 
normal serum of many mammalian species and agglutinates erythrocytes whose 
receptors have been altered by the action of enzymes produced by certain bffc- 
teria (1, 2) or by viruses of the mumps-influenza group (3). Attention was first 
directed to the agglutinin by its ability to introduce complications in blood- 
typing procedures when the erythrocyte suspensions were altered by the action 
of certain contaminating bacteria  (1).  The observation  that absorption  and 
spontaneous elution of certain viruses produce similar agglutinability (3) stimu- 
lated further interest in the agglutinin. The T-agglutinin titer was increased 
above the normal in sera from primary atypical pneumonia when cold agglu- 
tinin was also elevated, although T-agglutinin was found to be distinct from 
cold agglutinin (4).  No significant alteration in the T-agglutinin titer was ob- 
served, however, in human sera from mumps, influenza, psittacosis, or hepatitis 
(4). 
In an effort to gain insight into some of the mechanisms which influence infec- 
tion and immunity in anthrax, various serological and biochemical properties 
of the serum have been studied during the course of the infection. The mecha- 
nism of acquired immunity in anthrax appears to be related to that in typical 
virus  infections, in that it is not associated with the  activity of antibodies 
demonstrable by agglutination, precipitation,  or complement fixation (5).  It 
seemed possible, therefore, that alterations in cell receptors somewhat analagous 
to those in virus infections might take place and that these processes would be 
reflected in changes in tissue and serum factors associated with virus activity. 
The T-agglutinin titer was therefore studied during anthrax infection in the 
rabbit, and it was found that an abrupt decrease in titer frequently occurred 
during the acute phase of the infection. Observations on the nature and mechan- 
ism of this alteration in T-agglutinin titer are the subject of the present work. 
Materials  and  Methods 
The VoUum strain of B. antheacis was used. A spore suspension was prepared by growing 
the organism on nutrient agar for 3 days, harvesting in water, heating at 60°C.  for 30 minutes 
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to destroy vegetative cells, and washing and resuspending in water. These suspensions have 
been stored in the refrigerator and have shown no apparent change in viable count or viru- 
lence after 2 years. Rabbits were challenged by intracutaneous  injection on the back near the 
posterior axillary fine. The receptor-destroying enzyme (R.D.E.)  of V. cholerae was prepared 
by the method of Burnet and Stone (6), and stored at -20°C. in small tubes. No change in 
enzyme activity was noted after storage for 6 months under these conditions. The R.D.E.- 
treated  erythrocyte suspension was prepared  according to Lind  and McArthur (4), using 
normal human type O erythrocytes.  Rabbit serum samples were obtained from blood taken 
from the marginal ear vein or from the heart,  and were stored at  -20°C. until used. Sera 
from the various bleedings from each rabbit were titrated  in the same series of tests.  Sera 
were inactivated at 56°C. for 30 minutes before use. 
Serial 2-fold dilutions of the sera were prepared in saline in a volume of 0.5 ml. and 0.5 ml. 
of 1 per cent R.D.E.-treated  erythrocyte suspension added. The tests were incubated at 37°C. 
for a half hour, resuspended by shaking, and incubated for another half hour. They were then 
allowed to stand at room temperature for a half hour and read for the presence of macroscopic 
agglutination on resuspension. Titers  are recorded as the final dilution showing definite evi- 
dence of agglutination. 
EXPERIMENTAL  RESULTS 
A.  Changes in  T-Agglutinin  Titer during Anthrax In/ection.--T-agglutinin 
titers were determined on serum samples obtained from rabbits after intracu- 
taneous challenge with  104 spores of B. anthracis.  Most of these rabbits  were 
being used for assay of the anthrax protective antigen  (7)  and therefore had 
received injections of various culture filtrates.  The immunizing potency of the 
culture filtrates varied greatly, and accordingly the infections produced in the 
rabbits ranged from negative or minimal, as judged by the absence of any lesion 
at the challenge site,  to the rapidly extending fatal infection characteristic of 
the normal animal (8). The challenge dose was invariably fatal for unprotected 
animals,  and  they usually died on the 3rd or 4th day after challenge.  Serum 
samples were obtained before immunization,  shortly before challenge,  and at 
various intervals after challenge. 
Typical results of T-agglutinin titrations on sera from two animals are given 
in detail in Table I. The approximate degree of agglutination observed on re- 
suspending the settled erythrocytes is indicated by the number of plus marks. 
It will be observed that the T-agglutinin titer in rabbit  5-01  dropped  to less 
than 1-8 on the 3rd day after challenge; the rabbit was found dead on the fol- 
lowing day. Rabbit 3-77 had been immunized with an antigen preparation of 
moderate  protective  activity.  Serum  taken  on  the  5th  day  after  challenge 
showed a  marked decrease of T-agglutinin. The animal survived and the titer 
returned  to normal on the  13th day after challenge.  No significant change in 
T-agglutinin was noted as a  result of the immunization procedures. 
Mter the agglutination titrations had been recorded they were placed in the 
refrigerator and reexamined  the following day. It was observed that some of 
the acute-phase sera produced partial hemolysis of the erythrocytes under these 
conditions, as shown in Table I. This reaction is discussed in part C. OEOROE  O.  WRIOHT  AND  JANET  B.  SLEIN  101 
TABLE  I 
T-Aggl~in~i~  and Heraolys~u,  ith S~a Tak~ ~  I~erv~sbef~¢ and afterChall~gewitk 
B. anthr~ 
Rabbit 
3-77 
No.  Serum sample 
5-01  Before  immuniza- 
tion 
Before challenge 
Days  after  chal- 
lenge: 3:~ 
Before  immuniza- 
tion 
Before challenge 
Days  after 
lenge: 
5 
9 
13 
2O 
T-agglutination  Hemolysis* 
Serum dilution  Serum dilution 
1-8  1-16  .,1-32 
++  +  T+ 
++  ÷+  +  - 
++  Jr+  +  + 
++'I  ÷+  +  + 
chal-  +  +  +  _  _ 
÷+l++l+¢ 
+++  ++1  +  +  +++  +++  + 
1-64  1-128  1-8  1-16 
_  4-  -- 
-  +4 
+  - 
+  + 
-  -bq 
q-  - 
q-  - 
1-32  1-64 
+q  +q  ++ 
+-~  +-i  -i- 
1-128 
+ 
4- 
* After standing at 4°C. for 16 to 20 hours. 
:~ Rabbit dead  on 4th day  after challenge. 
TABLE  II 
Changes in T-A gglutinin Titer durin  Anthrax Infection in 95 Rabbi~s 
Per cent of 
Alteration  in T-agglutinin titer during infection  No. of animals  total animals  Survivors in 
tested  group 
No significant change ....................... 
Moderate decrease--less than 4-fold ........... 
Marked decrease---4-fold or greater ........... 
Increased .................................. 
No agglutinin present ....................... 
36 
26 
29 
3 
1 
38 
27 
31 
3 
1 
p~ ceng 
36 
35 
21 
33 
0 
The results of T-agglutinin titrations on sera from 95 challenged animals are 
summarized  in Table  II, which records  the number  of animals which showed 
no change in titer,  a  moderate  decrease of less than 4-fold, a  marked  decrease 
of 4-fold or greater, and an increase in titer. One rabbit was encountered whose 102  T-AGGLUTININ CHANGES DURING ANTHRAX 
serum showed no agglutination at a dilution of 1-20. It will be observed that 58 
per cent of the animals showed a significant decrease in titer during the infec- 
tion. In 38 per cent of the animals no significant change in titer was observed. 
Several factors presumably contributed to the appreciable size of this latter 
group. Some of the animals were resistant to infection as a result of the immuni- 
zation procedure, so that infection was absent or minimal in a number of them. 
The rabbits were bled in groups at rather wide time intervals, so that the time 
of bleeding was doubtless not optimum for the demonstration of a decrease in 
titer in many of the animals. In addition, the results are complicated somewhat 
by the presence of normal O-cell agglutinins in the sera of some of the rabbits. 
This factor would mask a decrease in T-agglutinin, especially when the normal 
T-titer was low. 
T-agglutinin titers of sera from different normal rabbits varied from 1-8 or 
less to 1-128. Titers of successive bleedings from the same normal animal, how- 
ever, were relatively constant. In animals which survived infection the T-agglu- 
tinin titer usually returned to the normal level, but not significantly above. 
Occasionally a 2-fold rise above the normal titer was observed, but the increase 
does not appear to be significant; evidently T-agglutinin is not directly involved 
in acquired immunity to anthrax. 
B.  Presence of a T-Agglutinin Inhibitor in Acute-Phase Sera.---The relatively 
abrupt decrease in T-agglutinin titer during the acute phase of the infection 
and its rapid return to normal during convalescence suggested that during the 
infection the serum acquired the ability to inhibit T-agglutination. Acute-phase 
sera were therefore tested for ability to inhibit the T-agglutinin of normal serum. 
Typical results with normal and acute-phase sera from four rabbits which had 
shown a  marked decrease in T-agglutinin are given in Table III.  It will be 
observed that acute-phase sera, but not normal sera, were capable of inhibiting 
the T-agglutinin of normal serum. Of the 29 acute-phase sera which had shown 
a markedly reduced titer of T-agglutinin 26 were examined for the presence of 
inhibitor of T-agglutinin; 20 were found to have detectable inhibitory activity, 
varying from partial inhibition at a dilution of 1-8 to almost complete inhibition 
at 1-128. The pattern of the inhibition effect varied considerably with sera from 
different animals, as is shown by the examples presented in Table III. With 
some sera the inhibition was complete in low dilutions and abruptly disappeared 
in higher dilutions.  In others partial inhibition appeared over a  considerable 
range of dilutions, and a quantitative end-point was therefore difficult to estab- 
lish. The present data suggest no explanation for this variability. 
The substance responsible for inhibition of T-agglutination did not appear 
to  be  related  to  the  polypeptide  (9)  or  polysaccharide  (10)  antigens  of  B. 
anthracis,  since it was found that as much as 0.1  rag. of these substances did 
not produce detectable inhibition of T-agglutination. Culture filtrates contain- 
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lesions in the rabbit (11) were also devoid of inhibitory activity. The substance 
in acute-phase sera responsible for inhibition of T-agglutination will therefore 
be referred to as T-inhibitor. 
Although T-agglutinin was not observed to increase significantly above the 
normal level on recovery from the infection, it seemed possible that the serum 
might acquire some new ability to neutralize T-inhibitor. This possibility was 
tested by substituting convalescent sera for normal serum in the T-inhibition 
titration. The convalescent sera were diluted so that, as with the normal serum, 
two agglutinating doses of serum were added to each tube. The inhibition titers 
TABLE III 
Effect of Normal and Acute-Phase Sera on T-Agglutination 
Rabbit serum tested 
3-66 before infection 
Acute phase 
3-71 before infection 
Acute  phase 
3-91 before infection 
Acute phase 
4-96 before infection 
Acute phase 
Final serum dilution 
1-8  1-16 
++  ++ 
+++_  +4-+ 
+++  +++ 
4-4-  4- 
%++  ++÷ 
1-32 
+++ 
+ 
++ 
++ 
14  1-128 
++  ++ 
+  ++ 
++  ++ 
4-  + 
++  ++ 
++  ++ 
++  ++ 
++  ++ 
Dilutions of the test sera in a volume of 0.25 ml. were mixed with an equal volume of 
normal serum diluted to contain two agglutinating units and incubated for 1 hour at 37°C.; 
0.S ml. of R.D.E.-treated erthrocyte suspension was then added, and the tests incubated and 
read for T-agglutination. 
of acute-phase sera were not found to change appreciably when convalescent 
serum was substituted for normal serum in the titration. This suggests that no 
increased ability to neutralize T-inhibitor accompanies acquired immunity to 
anthrax. 
C.  Hemolytic  Activity  of A cute-Pkase  Sera.--In  the  course of titmtions  of 
T-agglutinin it was observed that  those acute-phase sera in which a  marked 
decrease in T-agglutinin had occurred and in which excess T-inhibitor could be 
demonstrated usually produced definite hemolysis when the titrations were left 
at 4°C. overnight. Examples of this behavior are given in Table I. Of 20 sera 
found to contain T-inhibitor,  19 showed appreciable hemolytic activity. The 
intensity of hemolysis varied considerably, but was usually not complete even 
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Since the sera were inactivated for 30 minutes at 56°C. before titration, the 
reaction apparently did not require the presence of labile components of comple- 
ment. Inactivation of fresh serum at 56°C. for 10 minutes was found to produce 
an abrupt decrease in hemolytic activity; with normal sera or with sera devoid 
of T-inhibitor this treatment essentially destroyed hemolytic activity. Part of 
the hemolytic activity of acute-phase sera was also destroyed by this treatment, 
but the residual activity did not show appreciable further decrease after 1 hour 
at 56°C. In general the heat-stable hemolytic activity of acute-phase sera was 
correlated with the T-inhibitor activity, suggesting that the two effects may be 
produced by the same substance. 
Hemolytic activity was found to be inhibited in the presence of 0.05 •  sodium 
citrate; addition of calcium or magnesium ion did not, however, increase the 
hemolytic activity in the absence of citrate. Untreated human type 0 erythro- 
cytes were hemolyzed  approximately as readily as were R.D.E.-treated erythro- 
cytes. Untreated erythrocytes of other species gave irregular results with differ- 
ent hemolytic sera. Of 6 sera tested, 3 lysed rabbit erythrocytes nearly as well 
as human erythrocytes; 1 serum also lysed sheep erythrocytes. 
D.  In Vitro Changes in T-Agglutinin and T-Inhibitor Titers:--In the course 
of the work on T-agglutinin and T-inhibitor repeated titrations were frequently 
carried out on the same serum samples. While the agreement of these titrations 
was reasonably good, definite decreases in T-agglutinin were occasionally en- 
countered on retitration of acute-phase sera. The T-agglutinin titers of normal 
sera, however, were relatively constant. Although the sera were stored in the 
frozen state, they were occasionally thawed to remove small samples for these 
and other experiments, and were thus allowed to stand at room temperature 
for short intervals. It seemed possible, therefore, that T-inhibitor activity could 
appear in acute-phase sera in vitro. Preliminary experiments have shown that 
this can occur. 
Sera were incubated at 37°C. for various periods up to 20 hours at a dilution 
of 1-2 in saline which contained 1-5000 merthiolate. Merthiolate was included 
to prevent bacterial growth during the longer incubation times; its addition did 
not influence the reaction being studied. A number of freshly drawn acute-phase 
sera were observed to show a  gradual decrease in T-agglutinin titer or an in- 
crease in T-inhibitor titer and an increase in hemolytic activity on incubation 
at  37°C.  Normal  sera  also  showed decreases  in T-agglutinin  titer,  but  the 
changes were much less marked than with acute-phase sera. Further investiga- 
tions on the in vitro production of T-inhibitory activity are in progress. 
DISCUSSION 
It is not clear from present  evidence what relationship production of the 
T-inhibitor has to the fundamental processes of anthrax infection. It is possible 
that the mechanism which leads to production of T-inhibitor is a secondary and GEORGE  G.  WRIGHT  AND  JANET  B.  SLEIN  105 
non-specific response to acute infection. The hemolytic activity which appears 
to be associated with the presence of T-inhibitor, however, suggests that the 
substance is not without significance in the disease process; present evidence is 
not suificient to determine whether it plays a  role in the mechanism of death 
in anthrax. 
The factors studied 'appear  to bear  no direct relationship to  the immune 
response  to  anthrax  infection. The T-agglutinin titer  returns  to  normal on 
recovery, but has not been observed to increase significantly above the initial 
level. T-inhibitor would not appear to be identical with the protective antigen 
or the known serologically active antigens of B. anthracis. Convalescent serum 
appears to contain no neutralizing capacity for T-inhibitor in addition to its 
T-agglutinin activity. It seems possible, however, that immunity may involve 
suppression of those in vivo processes which lead to the production of T-inhibi- 
tor; experiments suggested by this hypothesis are in progress. 
Various findings suggest that the major phenomena under investigation are 
influenced and complicated by variables whose nature and precise effect are 
unknown at present. Thus the variation in the sharpness of the end-point in 
inhibition experiments suggests that some factor other than the concentration 
of the inhibitory substance plays a role in determining its effectiveness in in- 
hibiting T-agglutination. The observed variation in the hemolytic activity of 
different sera on erythrocytes of different species is also unexplained, although 
it may be related to the variation of normal agglutinin for the erythrocytes in 
the sera; preliminary data are compatible with the hypothesis that hemolysis 
of human and sheep erythrocytes is inhibited by the presence of normal agglu- 
tinin. It seems reasonable that the decrease in T-agglutinin is in some cases 
masked by the presence of normal antihuman agglutinins, since R.D.E.-treated 
erythrocytes retain their normal antigenic specificities to an appreciable extent 
(12).  In the present study we have investigated only what appeared to be the 
major and most general changes and effects; more detailed work can doubtless 
provide explanations for some of the more complex observations. 
SUMMARY 
An  abrupt  decrease  in  the  titer  of serum T-agglutinin frequently occurs 
during the acute phase of anthrax infection in the rabbit. In partially immunized 
animals which survive the infection the titer returns to normal during convales- 
cence, but has not been observed to rise significantly above the normal level. 
The presence of a  substance capable of inhibiting T-agglutination may be 
demonstrated in the sera of many of those animals in which a marked decrease 
in T-agglutinin has occurred. The polysaccharide and polypeptide antigens of 
B. anthracis do not possess this activity. 
Sera containing the T-inhibitory substance usually produce a slow hemolysis 
of T-erythrocytes and also of normal human type O erythrocytes; hemolysis of 106  T-AGGLUTINT~  CHANGES  DURING  ANTHRAX 
erythrocytes of other species is irregular. This reactivity of the sera withstands 
inactivation at 56°C. but is inhibited by citrate. 
T-inhibitory and hemolytic activities can frequently be increased by incuba- 
tion of the acute-phase serum at 37°C. 
The  ability of normal  serum to neutralize  the T-inhibitory  and  hemolytic 
activities of acute-phase serum is not significantly increased after recovery from 
the infection. 
The meaning  of the results is discussed. 
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